DV Equities, LLC reported 73 positions worth $396.06M for the quarter ended Jun 30, 2026. Its largest holding is Sony Group Corp at 12.8% of the portfolio.
Reported 13F market value at each quarter end. A change mixes trading with price moves in the positions held.
Dollar value of shares bought and sold each quarter, at that quarter’s price. It counts trading only, not price changes.
How many positions were opened, added to, trimmed or closed each quarter.
Share of reported value in each sector at every quarter end.
| # | Activity | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | SONY Sony Group Corp | Technology | 2.53M | $50.74M | 12.81% | – | – | – | 0.04% |
| 2 | TNGX Tango Therapeutics, Inc. | Healthcare | 1.32M | $41.22M | 10.41% | – | – | – | 0.78% |
| 3 | HMC Honda Motor Co Ltd | Consumer Discretionary | 1.52M | $41.22M | 10.41% | – | – | – | 0.1% |
| 4 | NVO Novo Nordisk A S | Healthcare | 631.2K | $30.26M | 7.64% | – | – | – | 0.01% |
| 5 | PHVS Pharvaris N.V. | Healthcare | 482.5K | $16.69M | 4.21% | – | – | – | 0.82% |
| 6 | MU Micron Technology Inc | Technology | 13.0K | $15.03M | 3.8% | – | – | – | 0% |
| 7 | GOOGL Alphabet Inc. | Technology | 29.1K | $10.38M | 2.62% | – | – | – | 0% |
| 8 | DEO Diageo Plc | Consumer Staples | 126.0K | $10.13M | 2.56% | – | – | – | 0.02% |
| 9 | BP Bp Plc | Energy | 272.9K | $10.08M | 2.55% | – | – | – | 0.01% |
| 10 | GSK GSK plc | Healthcare | 188.8K | $9.89M | 2.5% | – | – | – | 0.01% |
| 11 | MSFT Microsoft Corp | Technology | 25.4K | $9.49M | 2.4% | – | – | – | 0% |
| 12 | RVMD Revolution Medicines, Inc. | Healthcare | 47.7K | $8.93M | 2.25% | – | – | – | 0.02% |
| 13 | MANE Veradermics, Inc | Healthcare | 70.0K | $8.61M | 2.17% | – | – | – | 0.17% |
| 14 | ING Ing Groep Nv | Financial Services | 239.3K | $7.51M | 1.9% | – | – | – | 0.01% |
| 15 | SNDK Sandisk Corp | Technology | 2,798 | $6.36M | 1.61% | – | – | – | 0% |
Tip. Select a row to see that position’s full history at Dv Equities.
As of its Q2 2026 13F filing, DV Equities, LLC’s five largest positions were Sony Group Corp (SONY) at 12.8%, Tango Therapeutics, Inc. (TNGX) at 10.4%, Honda Motor Co Ltd (HMC) at 10.4%, Novo Nordisk A S (NVO) at 7.6%, Pharvaris N.V. (PHVS) at 4.2% of the reported portfolio.
DV Equities, LLC reported a 13F portfolio worth $396.06M across 73 positions for Q2 2026.
From the Form 13F-HR reports DV Equities, LLC files with the SEC each quarter, within 45 days of quarter end. A 13F lists long positions in US-listed equities and options; it excludes short positions, cash, bonds and most non-US holdings.
13F data reflects long positions in US-listed equities and options as reported to the SEC up to 45 days after quarter end. It excludes short positions, cash, bonds and most non-US securities, so it is not a complete picture of a manager’s assets.